Evoke Pharma
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
420 Stevens Ave Ste 230, Solana Beach, C...Phone Number
(858) 345-1494Website
www.evokepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Evoke Pharma
Evoke is a specialty pharmaceutical company focused primarily on the commercialization and development of drugs to treat GI disorders and diseases. The company developed GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.Explore more
Evoke Pharma Org Chart
RM
Gastroenterology Care Specialist
JW
Gastroenterology Care Specialist
TL
Gastroenterologist Care Specialist
KF
Gastroenterology Care Specialist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Evoke Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Evoke Pharma
Click to see if Evoke Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Evoke Pharma has new funding data
Check if Evoke Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Evoke Pharma recently announced quarterly report
Product Launch: Get notified when Evoke Pharma launches new products
Website visits: Recent activity has been detected on your website
Check out if Evoke Pharma is spiking on competitors!
Evoke Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Evoke Pharma
Compare insights from companies similar to Evoke Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Evoke Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Evoke Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Evoke Pharma.
Evoke Pharma financials insights
Gather financial insights about Evoke Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$25.2M
2024
Stock Offering
$3.5M
Evoke Pharma Tech Stack
A closer look at the technologies used by Evoke Pharma
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Earnings
reported revenue of $10.2 million for 2024, a 97% year-over-year increase, exceeding guidance of $10 million. Q4 revenue was $3.3 million, a 24.6% sequential increase.
Earnings, Business Intelligence, Analytics & Insights, Accounting, Financial Reporting, Finance
Project
Evoke Pharma has announced that its strategy for 2025 and beyond focuses on extending pharmacy partnerships, increasing provider awareness and engagement, leveraging real-world data for payer discussions, and improving prescription fulfillment rates for Genuity.
Customer Engagement, Healthcare Operations, Marketing Strategy
Project
strengthened its corporate position with two additional Orange Book listed patents for Genuity in 2024, bringing the total to six listed patents extending into 2030.
Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Business Intelligence, Analytics & Insights, Customer Engagement, Healthcare Operations
Evoke Pharma News & Media
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, Nov. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Evoke (NASDAQ: EVOK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction. Click here to learn how to join our investigation and obtain additional information or...Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashEvoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
Separately Secures Access to OneGI Through Brentwood Pharmacy AgreementEvoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that U.S. Patent No. 12,377,064 covering the use of GIMOTI® (metoclopramide) nasal spray in patients with moderate to severe symptoms of gastroparesis, has been listed in the U.S. Food and Drug Administration’s (FDA) Approved Drug Pr
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Evoke Pharma
Sign Up For FreeTo access detailed company insights
Evoke is a specialty pharmaceutical company focused primarily on the commercialization and development of drugs to treat GI disorders and diseases. The company developed GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.... Read More
